Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NS1209

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract Preclinical Research The selective AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor antagonist… Expand
Is this relevant?
2013
2013
Refractory status epilepticus (RSE) is a life-threatening condition that requires immediate and aggressive treatment… Expand
  • table 1
  • table 2
Is this relevant?
2011
2011
Epileptogenesis, i.e., the process leading to epilepsy, is a presumed consequence of brain insults including head trauma, stroke… Expand
Is this relevant?
2009
2009
BACKGROUND Chronic neuropathic pain is inadequately treated using current therapies, with less than half of patients achieving… Expand
  • figure 2
  • table 1
  • figure 3
  • figure 4
  • table 2
Is this relevant?
2009
2009
The successful treatment of most diseases relies heavily upon early detection. Biomarkers with diagnostic and prognostic value… Expand
Is this relevant?
2007
2007
The current first line treatment of status epilepticus (SE) is based on the use of compounds that enhance GABAergic transmission… Expand
Is this relevant?
Review
2006
Review
2006
There is a remarkable array of new chemical entities in the current antiepileptic drug (AED) development pipeline. In some cases… Expand
Is this relevant?
2004
2004
The effects of systemic administration of the novel AMPA/GluR5 selective receptor antagonist NS1209 in animal models of… Expand
Is this relevant?
2004
2004
Previous studies have shown that repeated injections of acidic saline, given into the lateral gastrocnemius muscle of rats… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The spared nerve injury (SNI) model involves a lesion of two of the three terminal branches of the sciatic nerve (tibial and… Expand
Is this relevant?